| 2.87 -0.13 (-4.33%) | 12-01 15:59 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 4.11 |
1-year : | 4.59 |
| Resists | First : | 3.52 |
Second : | 3.93 |
| Pivot price | 3.34 |
|||
| Supports | First : | 2.85 |
Second : | 2.37 |
| MAs | MA(5) : | 3.03 |
MA(20) : | 3.41 |
| MA(100) : | 3.33  |
MA(250) : | 2.8 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 1.7 |
D(3) : | 3.5 |
| RSI | RSI(14): 31.2 |
|||
| 52-week | High : | 5.9 | Low : | 1.22 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ CHEK ] has closed above bottom band by 1.7%. Bollinger Bands are 1.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 3.05 - 3.07 | 3.07 - 3.09 |
| Low: | 2.86 - 2.89 | 2.89 - 2.9 |
| Close: | 2.88 - 2.91 | 2.91 - 2.94 |
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
Tue, 28 Nov 2023
Symetryx Today Issues Open Letter to Shareholders In Regard to ... - Yahoo Finance
Mon, 27 Nov 2023
2023-11-27 | NDAQ:CHEK | Press Release | Check Cap Ltd - Stockhouse Publishing
Fri, 24 Nov 2023
Where Does Check Cap Ltd (CHEK) Stock Fall in the Diagnostics & Research Field After It Is Lower By -5.52% This Week? - InvestorsObserver
Mon, 13 Nov 2023
Keystone Dental Announces Launch of the GENESIS ACTIVE ... - Yahoo Finance
Mon, 06 Nov 2023
Keystone Dental Announces Market Launch of Nexus Connect, the ... - GlobeNewswire
Wed, 16 Aug 2023
Keystone Dental Holdings and Check-Cap Ltd Enter into Definitive ... - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Diagnostics & Research
|
|
| Shares Out | 6 (M) |
| Shares Float | 5 (M) |
| Held by Insiders | 0.1 (%) |
| Held by Institutions | 2.5 (%) |
| Shares Short | 86 (K) |
| Shares Short P.Month | 123 (K) |
| EPS | -3.37 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.15 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -28.8 % |
| Return on Equity (ttm) | -49.8 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -3.39 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -18 (M) |
| Levered Free Cash Flow | -12 (M) |
| PE Ratio | -0.85 |
| PEG Ratio | 0 |
| Price to Book value | 0.55 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.93 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|